HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis.

Abstract
Systemic-onset juvenile idiopathic arthritis is an inflammatory disease of unknown cause and is not commonly associated with kidney involvement. We describe 3 patients with systemic-onset juvenile idiopathic arthritis with high disease activity who developed antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis 1-6 years after the onset of systemic-onset juvenile idiopathic arthritis. Renal and systemic-onset juvenile idiopathic arthritis remission occurred in one patient under anti-interleukin 1 (anti-IL-1) treatment associated with immunosuppressive drugs. The other 2 patients developed end-stage renal disease, and one of those patients died. This report suggests that the diagnosis of ANCA-associated glomerulonephritis must be considered in patients with systemic-onset juvenile idiopathic arthritis with persistently active systemic disease who present with proteinuria. Furthermore, use of an anti-IL-1 agent might be an effective therapeutic option.
AuthorsAlexandre Belot, Brigitte Bader-Meunier, Patrick Niaudet, Rémi Salomon, Anne-Marie Prieur, Laure-Hélène Noel, Pierre Quartier
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 59 Issue 3 Pg. 439-43 (Mar 2012) ISSN: 1523-6838 [Electronic] United States
PMID22189036 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Antibodies, Antineutrophil Cytoplasmic
  • Arthritis, Juvenile (complications)
  • Child, Preschool
  • Female
  • Glomerulonephritis (complications, immunology)
  • Humans
  • Infant
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: